Carregant...
Refractory acute promyelocytic leukemia successfully treated with combination therapy of arsenic trioxide and tamibarotene: A case report
A 40-year-old male developed refractory acute promyelocytic leukemia (APL) after various treatments including all-trans retinoic acid, tamibarotene, arsenic trioxide (As(2)O(3)), conventional chemotherapy, and autologous peripheral blood stem cell transplantation. We attempted to use both tamibarote...
Guardat en:
| Publicat a: | Leuk Res Rep |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4840419/ https://ncbi.nlm.nih.gov/pubmed/27144119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lrr.2016.01.001 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|